Day: April 11, 2023

HOUSTON, April 11, 2023 (GLOBE NEWSWIRE) — Freight Technologies, Inc. (Nasdaq: FRGT, Fr8Tech or Company), a technology company developing solutions to optimize and automate the supply chain process and providing its Fr8App platform for B2B cross-border shipping in the USMCA region, Fr8now for LTL shipping services in Mexico and Fr8Fleet for dedicated capacity to enterprise companies in Mexico, previously announced that it received written notification on October 26, 2022, from The Nasdaq Stock Market LLC that it no longer complied with the minimum bid price requirement for continued listing on the Nasdaq Capital Market pursuant to the Nasdaq Listing Rule 5550(a)(2). The closing bid price for the Company’s ordinary shares had fallen below $1.00 per share for 30 consecutive business days and accordingly, the Company no longer...

LAS VEGAS, April 11, 2023 (GLOBE NEWSWIRE) — HF Foods Group Inc. (NASDAQ: HFFG), a leading food distributor to Asian restaurants across the United States (“HF Foods” or the “Company”), today announced that the Board of Directors (the “Board”) has approved the adoption of a limited duration stockholder rights plan (the “Rights Plan”) and declared a dividend distribution of one right (“Right”) for each outstanding share of the Company’s common stock to stockholders of record as of the close of business on April 24, 2023. The Board adopted the Rights Plan out of concern that parties may be engaging in undisclosed stock accumulation and group formation activities to gain control of HF Foods, depriving stockholders of both the opportunity to realize the full value of their investment in the Company and the opportunity to determine the...

SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that the company will present seven posters collectively highlighting data out of five of its liver disease programs at the European Association for the Study of the Liver (EASL) Congress 2023, taking place in Vienna, Austria, June 21 – 24, 2023. The presentations will be available on the Scientific Presentations and Conferences page on Aligos’ corporate website following the meeting. “We are pleased to present seven abstracts at this year’s EASL meeting,” said Lawrence Blatt, Ph.D., MBA, Chairman & CEO of Aligos Therapeutics. “We believe these programs demonstrate...

SANTIAGO, Chile, April 11, 2023 (GLOBE NEWSWIRE) — BANCO ITAÚ CHILE (NYSE: ITCB; SSE: ITAUCORP) announced that it filed today a Material Event Notice with the Chilean Commission for the Financial Market reporting that on this date, the settlement and placement of Banco Itaú Chile dematerialized and bearer bonds in the local market, charged to the Line of Bonds registered in the Securities Registry of the CMF, under No. 3/2022. The specific conditions of placement were as follows:Series “DP” Bonds, Code BITADP0222, for a total amount of UF 1,500,000 (Unidades de Fomento), collecting the sum of CLP $ 51,198,697,758.- with a maturity date of August 9, 2034, at an average placement rate of 2.68%.The full Material Event Notice is available on the company’s investor relations website at ir.itau.cl. Investor Relations – Itaú Chile +56...

CALGARY, Alberta, April 11, 2023 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE) (TSX:GTE) (LSE:GTE) is pleased to announce that the Company has entered into an agreement with Ecopetrol S.A. (“Ecopetrol”), the national oil company of Colombia, by which the parties renegotiated the terms and the duration of the contract for the Suroriente Block (“Suroriente”) in the Department of Putumayo, which was scheduled to end in mid-2024 (the “Agreement”). All dollar amounts are in United States (“U.S.”) dollars unless otherwise indicated. The Agreement provides an opportunity to add significant value, as well as economic life, to Suroriente by continuing its duration for 20 years from the Agreement’s effective date. The additional term of the contract allows long-term investment in infrastructure...

Company to share preliminary safety and efficacy data from ongoing Phase 1/2 trial of OCU400 for the treatment of retinitis pigmentosa and Leber congenital amaurosis MALVERN, Pa., April 11, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that it will host an Investor and Analyst Event on April 14, 2023, at 8 a.m. ET. During the webcast and conference call, members of the Ocugen leadership team and key opinion leaders will review preliminary safety and efficacy results from the Phase 1/2 trial of OCU400 for the treatment of retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA). The event will feature: Shankar Musunuri, PhD, MBA, Chairman, CEO...

HOUSTON, April 11, 2023 (GLOBE NEWSWIRE) — Nauticus Robotics, Inc. (“Nauticus” or the “Company”) (NASDAQ: KITT), a developer of ocean robots using artificial intelligence for data collection and intervention services, today announced it will hold its Annual Meeting of Stockholders (the “Annual Meeting”) on Wednesday, May 10, 2023 at 10:00 a.m. Central Time. The Annual Meeting will be held in a virtual format to provide a consistent experience to all of the Company’s stockholders regardless of location at www.proxydocs.com/KITT. At the Annual Meeting, stockholders will be asked to consider and vote upon the following matters:The election of Class I director nominees of Nauticus, named in the proxy statement for the Annual Meeting, each to serve for a term of 3 years until the 2026 annual meeting of stockholders; The ratification...

HOUSTON, April 11, 2023 (GLOBE NEWSWIRE) — Skyward Specialty Insurance Group™ (NASDAQ: SKWD) (“Skyward Specialty” or “the Company”) expects to issue its first quarter 2023 earnings results after the market closes on Tuesday, May 9, which will be available on the Company website at investors.skywardinsurance.com/ under Quarterly Results. Skyward Specialty will host its earnings call to review first-quarter 2023 financial results on Wednesday, May 10 at 10 a.m. CST. Investors may access the live audio webcast via the link on the Company’s investor site at investors.skywardinsurance.com/ under Events & Presentations. Additionally, investors can access the earnings call via conference call by registering via the conference link. Users will receive dial-in information and a unique PIN to join the...

VANCOUVER, British Columbia, April 11, 2023 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE: SLI) (FRA: S5L), a leading near-commercial lithium company, will participate in the following investor conference.Event: Echelon Partners Lithium SummitDate: April 13th 10:00 AM PTLocation: VirtualEvent Registration: LinkFor non Echelon clients who are interested in registering for the virtual event, enter “None” in the requested salesperson field.   On behalf of the Board of Standard Lithium Ltd.Robert Mintak, CEO & Director About Standard Lithium Ltd. Standard Lithium is a leading near-commercial lithium development company with a portfolio of projects in process. The Company’s flagship projects, the LANXESS Property Project and the South West Arkansas Project, are located...

New York, NY, April 11, 2023 (GLOBE NEWSWIRE) —  InterPrivate IV InfraTech Partners Inc. (Nasdaq: IPVIU, IPVI, IPVIW) (the “Company”) announced today that it will redeem all of its issued and outstanding shares of Class A common stock (the “Public Shares”), because the Company’s sponsor has determined that it will not make an additional contribution to the Company’s trust account required in order to further extend the April 9, 2023 deadline under the Company’s Amended and Restated Certificate of Incorporation (the “Charter”) for the Company to complete an initial business combination. Following such redemption of the Public Shares, the Company will liquidate and dissolve in accordance with the provisions of the Charter. The Company anticipates that the Public Shares will cease trading at or around the close of business on April...